Heidmar Maritime Holdings Corp. Update on Common Share Purchases by CEO

Heidmar Maritime Holdings Corp. Update on Common Share Purchases by CEO GlobeNewswire October 22, 2025 ATHENS, Greece and NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — Heidmar Maritime Holdings Corp. (the “Company” or “Heidmar”) (NASDAQ: HMR) announced today that its Chief Executive Officer, Pankaj Khanna, purchased 55,900 shares of the Company's common stock in the […]

ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology

ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology GlobeNewswire October 22, 2025 Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating Potential UNIONDALE, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) — ProPhase Labs Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation

FG Nexus Signs Non-Binding Letter of Intent to Sell Quebec Property

FG Nexus Signs Non-Binding Letter of Intent to Sell Quebec Property GlobeNewswire October 22, 2025 Charlotte, NC, Oct. 22, 2025 (GLOBE NEWSWIRE) — FG Nexus (Nasdaq: FGNX, FGNXP) (the “Company” or “FG Nexus”), today announced that it has signed a non-binding letter of intent to sell its Quebec property for $10 million. Following repayment of

Digi Power X Appoints Wealth Management Leader Ajay Gupta to its Board of Directors

Digi Power X Appoints Wealth Management Leader Ajay Gupta to its Board of Directors This news release constitutes a “designated news release” for the purposes of the Company's prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025 GlobeNewswire October 22, 2025 MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE)

Reckoner Capital Management Expands Alternative Credit Suite with Launch of BBB-B CLO ETF

Reckoner Capital Management Expands Alternative Credit Suite with Launch of BBB-B CLO ETF Actively managed ETF offers investors access to BBB- and BB-rated CLO bonds in easily accessible format GlobeNewswire October 22, 2025 NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — Reckoner Capital Management (“Reckoner”), a global asset management firm with specialized expertise in alternative

ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group

ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group GlobeNewswire October 22, 2025 Appointment reinforces ProMIS Neurosciences' strategic vision and deepens investor engagement as the Company advances its differentiated Alzheimer's program, PMN310 Cambridge, Massachusetts, Oct. 22, 2025 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc.

Saia Announces Retirement of CIO Rohit Lal and Appointment of Successor Tarak Patel

Saia Announces Retirement of CIO Rohit Lal and Appointment of Successor Tarak Patel GlobeNewswire October 22, 2025 JOHNS CREEK, Ga., Oct. 22, 2025 (GLOBE NEWSWIRE) — Saia, Inc. (Nasdaq: SAIA), a leading transportation provider offering national less-than-truckload (LTL), non-asset truckload, expedited and logistics services, today announced that Rohit Lal, Executive Vice President and Chief Information

United Community Banks, Inc. Reports Third Quarter Earnings

United Community Banks, Inc. Reports Third Quarter Earnings Strong Loan Growth and Margin Expansion Drive Higher Revenue and EPS GlobeNewswire October 22, 2025 GREENVILLE, S.C., Oct. 22, 2025 (GLOBE NEWSWIRE) — United Community Banks, Inc. (NYSE: UCB) (United) today announced net income for the third quarter of 2025 of $91.5 million and pre-tax, pre-provision income

Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 2025

Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 2025 GlobeNewswire October 22, 2025 Dapirolizumab pegol (DZP) Phase 3 study presentations in SLE to show efficacy results across multiple clinical endpoints, including low disease activity/remission, flares, fatigue, joint pain and quality of life Presentation of

FinWise Bancorp Announces Strategic Program Agreement with DreamFi, Inc. to Provide Financial Products that Empower Underbanked Communities to Build Financial Stability

FinWise Bancorp Announces Strategic Program Agreement with DreamFi, Inc. to Provide Financial Products that Empower Underbanked Communities to Build Financial Stability GlobeNewswire October 22, 2025 MURRAY, Utah, Oct. 22, 2025 (GLOBE NEWSWIRE) — FinWise Bancorp (NASDAQ: FINW) (“FinWise” or the “Company”), parent company of FinWise Bank (the “Bank”), today announced a strategic program agreement with

Scroll to Top